Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:540-545
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, P. D.
Right arrow Articles by Goldberg, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, P. D.
Right arrow Articles by Goldberg, S. J.

Cardiac teratogenicity of trichloroethylene metabolites

Paula D. Johnson, DVM, MSa, Brenda V. Dawson, MD* and Stanley J. Goldberg, MD, FACCa

a Department of Pediatrics, Steele Memorial Children’s Research Center, Southwest Environmental Health Science Center, University of Arizona, Tucson, Arizona, USA
* Department of Internal Medicine, Steele Memorial Children’s Research Center, Southwest Environmental Health Science Center, University of Arizona, Tucson, Arizona, USA



View larger version (24K):

[in a new window]
 
Figure 1 Percent of abnormal hearts (fetal basis). CMC = carboxy methylcystine; DCAA = dichloroacetic acid; DCAld = dichloroacetaldehyde; DCVC = dichlorovinyl cystine; MCAA = monochloroacetic acid; TCAA = trichloroacetic acid; TCAld = trichloroacetaldehyde; TCEth = trichloroethanol. *Statistical significance between the treated group and the control group.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement